Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. (SHE:300452)

SHE:300452 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 29, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,775	2,817	3,308	4,071	3,916	3,094
Market Cap Growth	-7.53%	-14.85%	-18.74%	3.96%	26.59%	46.83%
Enterprise Value	2,465	2,573	3,058	3,852	3,747	2,995
Last Close Price	11.93	12.11	13.97	16.94	16.01	12.46
PE Ratio	24.20	23.59	20.48	31.15	43.88	32.93
Forward PE	12.97	62.00	62.00	62.00	62.00	62.00
PS Ratio	3.11	3.19	3.94	5.78	6.35	5.82
PB Ratio	2.71	2.89	3.54	5.16	5.55	4.72
P/TBV Ratio	3.10	3.30	4.27	6.47	7.17	6.14
P/FCF Ratio	30.76	31.17	42.76	62.16	54.13	48.19
P/OCF Ratio	22.72	23.81	25.01	30.65	37.72	36.16
EV/Sales Ratio	2.76	2.92	3.64	5.47	6.08	5.64
EV/EBITDA Ratio	10.69	11.32	15.07	24.52	29.33	23.17
EV/EBIT Ratio	13.94	14.58	18.62	31.83	40.26	30.71
EV/FCF Ratio	27.33	28.46	39.53	58.80	51.79	46.65
Debt / Equity Ratio	0.31	0.31	0.32	0.05	0.04	0.06
Debt / EBITDA Ratio	1.37	1.34	1.47	0.25	0.24	0.31
Debt / FCF Ratio	3.51	3.37	3.85	0.61	0.43	0.62
Asset Turnover	0.57	0.57	0.62	0.66	0.66	0.62
Inventory Turnover	8.00	6.66	6.20	5.86	6.93	7.69
Quick Ratio	4.45	3.92	3.04	1.42	2.06	1.95
Current Ratio	4.94	4.38	3.44	1.83	2.48	2.26
Return on Equity (ROE)	11.75%	12.62%	19.10%	17.52%	12.57%	14.94%
Return on Assets (ROA)	7.06%	7.11%	7.54%	7.06%	6.24%	7.12%
Return on Capital (ROIC)	8.50%	8.78%	9.96%	9.66%	8.13%	9.35%
Return on Capital Employed (ROCE)	12.90%	13.30%	12.90%	14.50%	12.60%	14.30%
Earnings Yield	4.21%	4.24%	4.88%	3.21%	2.28%	3.04%
FCF Yield	3.25%	3.21%	2.34%	1.61%	1.85%	2.08%
Dividend Yield	2.10%	-	1.79%	1.48%	1.44%	1.54%
Payout Ratio	50.47%	49.41%	37.01%	42.33%	51.90%	37.34%
Buyback Yield / Dilution	1.93%	2.88%	-3.29%	0.63%	-1.93%	1.27%
Total Shareholder Return	4.03%	2.88%	-1.50%	2.10%	-0.49%	2.81%

Updated Oct 22, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.